A61K 49 - Preparations for testing in vivo

Patents for A61K 49 - Preparations for testing in vivo (35,376)
11/1992
11/25/1992	CA2069459A1 Polycondensates which contain tartaric acid derivatives, processes for their preparation and use thereof
11/24/1992	WO1992021017A1 Liposoluble compounds for magnetic resonance imaging
11/24/1992	US5165912 Reagents for diagnosis with antibodies reactive with enzymes
11/24/1992	CA2102605A1 Liposoluble compounds for magnetic resonance imaging
11/19/1992	EP0513783A2 Method for the removal of contaminants from perfluorinated alkyl bromides or alkylene dibromides
11/17/1992	US5164489 Protein growth factor useful in diagnosis and treatment of lung cancer
11/17/1992	US5164308 Preparation of labelled triglyceride oils by cultivation of microorganisms
11/12/1992	WO1992019975A1 Fluorophore assisted carbohydrate electrophoresis diagnosis
11/12/1992	WO1992019272A1 Porous inorganic ultrasound contrast agents
11/12/1992	WO1992019264A1 Biomodulators as universal imaging agents
11/12/1992	WO1992019261A1 Use of vasoactive intestinal peptide (vip) to induce temporary paralysis of the gastrointestinal tract
11/12/1992	WO1992019213A2 Enhancement of abnormal tissue uptake of antibodies, tumor-specific agents or conjugates thereof for diagnostic imaging or therapy
11/12/1992	WO1992017214A3 Physically and chemically stabilized polyatomic clusters for magnetic resonance image and spectral enhancement
11/12/1992	WO1992017152A3 Method for detecting and treating alzheimer's disease
11/11/1992	WO1992000749A1 Anti-herpes virus and cytomegalovirus oligomers
11/11/1992	EP0512693A1 Preparation of diagnostic agents
11/11/1992	EP0512661A1 Macrocyclic polymer-complexing, their complexes, method for their production and pharmaceutical agents containing them
11/11/1992	EP0512292A2 Composition for disclosing dental plaque containing cobalamin
11/11/1992	CN1066073A Polyazamacrocyclic compounds for complexation of metal ions
11/11/1992	CA2068266A1 Macrocyclic polymer complexing agents, their complexes, process for their production and pharmaceutical agents containing these compounds
11/10/1992	US5162525 Fluorogenic and chromogenic three-dimensional ionophores as selective reagents for detecting ions in biological fluids
11/10/1992	US5162231 Method of using 5,10,15,20-tetrakis(carboxyphenyl)porphine for detecting cancers of the lung
11/10/1992	US5162218 Conjugated polypeptides and methods for their preparation
11/10/1992	US5162109 Zwitterion Complexes of Paramagnetic Ions
11/10/1992	US5161531 Method and apparatus for intravascularly measuring oxidative metabolism in body organs and tissues
11/07/1992	CA2067989A1 Composition for disclosing dental plaque
11/04/1992	EP0511275A1 Chelating compounds
11/04/1992	EP0511273A1 Liposomes as contrast agents for ultrasonic imaging
11/03/1992	US5160726 Filter sterilization for production of colloidal, superparamagnetic MR contrast agents
11/03/1992	US5160725 Magnetic liquid compositions
11/03/1992	US5160724 Barium sulfate contrast medium for x-ray examination of the large intestine
11/03/1992	US5160437 Pressing through crosslinked membrane to force low molecular weight impurities out through pores
10/1992
10/29/1992	WO1992018874A1 Assessment of renal malfunction by esr spectroscopy
10/29/1992	WO1992018529A1 Increasing blood-brain barrier permeability with permeabilizer peptides
10/29/1992	WO1992018169A1 An organ specific emulsion
10/29/1992	WO1992018167A1 Material
10/29/1992	WO1992018165A2 Improved fluorocarbon contrast media for use with mri and radiographic imaging
10/29/1992	WO1992018164A1 Preparation of diagnostic agents
10/29/1992	CA2109094A1 An organ specific emulsion
10/29/1992	CA2083260A1 Preparation of diagnostic agents
10/28/1992	EP0510074A1 Porphyrin derivatives and metalloporphyrins optionally coupled with a biologically active molecule, and pharmaceutical composition containing same
10/28/1992	EP0510030A1 Transition metal complexes for magnetic resonance diagnosis
10/28/1992	EP0290496B1 Use of an adenosine, hypoxanthine and ribose-containing solution for improved protection of the heart during surgery
10/28/1992	CN1065595A Parenteral applicable, heat-sterilizable oil-in-water-emulsion of x-ray contrast medium
10/27/1992	US5159060 Cytotoxic boronic acid peptide analogs
10/27/1992	CA1309340C Cationized antibodies for delivery through the blood-brain barrier
10/26/1992	WO1992019732A1 Closed sense and antisense oligonucleotides and uses thereof
10/26/1992	CA2102229A1 Closed sense and antisense oligonucleotides and uses thereof
10/22/1992	DE4111939A1 Parenteral verabreichbare, hitzesterilisierbare o/w-emulsion eines roentgenkontrastmittels Parenterally administrable, heat sterilizable o / w emulsion-a roentgenkontrastmittels
10/21/1992	CN1065400A Sodium alginate couplant for ultrasonic diagnostic instrument
10/16/1992	WO1992018166A1 Melanin-based agents for image enhancement
10/16/1992	CA2108362A1 Melanin-based agents for image enhancement
10/15/1992	WO1992017514A1 Low density microspheres and their use as contrast agents for computed tomography
10/15/1992	WO1992017436A1 Cross-linking agent
10/15/1992	WO1992017215A1 Contrast media
10/15/1992	WO1992017214A2 Physically and chemically stabilized polyatomic clusters for magnetic resonance image and spectral enhancement
10/15/1992	WO1992017213A1 Improvements in or relating to contrast agents
10/15/1992	WO1992017212A1 Improvements in or relating to contrast agents
10/15/1992	WO1992007939A3 Polypeptide with 46kd hmfg differentiation antigen binding specificity
10/15/1992	DE4111914A1 Werkstoff Material
10/14/1992	EP0452330A4 Method and apparatus for diagnosing intracellular parasite infections using an enzyme detection system
10/13/1992	WO1992018168A1 Parenterally administrable, heat sterilisable o/w emulsions of an x-ray contrast agent
10/13/1992	US5155224 Protonated, insoluble magnetic resonance imaging contrast agents
10/13/1992	US5155218 Dna encoding human 5-ht1d receptors
10/13/1992	US5155215 Tumor diagnosis
10/13/1992	US5155212 Substituted phencyclidine compound linked to polyamino acid
10/13/1992	US5154914 Methods of diagnostic image analysis using lipophilic contrast agents
10/13/1992	CA2101430A1 Parenterally administrable, heat sterilisable o/w emulsions of an x-ray contrast agent
10/07/1992	EP0506880A1 Organo-metallic coated particles for use in separations
10/07/1992	EP0295242B1 Freeze-dried foam
10/03/1992	WO1992017216A1 Delivery of x-ray contrast agents using receptor mediated endocytosis
10/03/1992	CA2105068A1 Delivery of x-ray contrast agents using receptor mediated endocytosis
10/02/1992	WO1992017152A2 Method for detecting and treating alzheimer's disease
10/02/1992	CA2107589A1 Method for detecting and treating alzheimer's disease
10/01/1992	WO1992016240A1 Debridement of bodily cavities using debridement fluids
09/1992
09/30/1992	EP0505479A1 Method and device for detecting and quantifying glucose in body fluids
09/30/1992	EP0505357A1 Method for antibody targeting of diagnostic or therapeutic agents
09/29/1992	US5151264 Particulate vector useful in particular for the transport of molecules with biological activity and process for its preparation
09/29/1992	CA2107106A1 Cross-linking agent
09/28/1992	CA2106976A1 Contrast media
09/24/1992	DE4109169A1 Wasserloesliche nicht ionische roentgenkontrastmittel sowie mittel und verfahren zu ihrer herstellung Wasserloesliche nonionic roentgenkontrastmittel as well as medium and process for their production
09/23/1992	EP0504881A2 Booster for therapy of diseases with ultrasound and pharmaceutical liquid composition containing the same
09/23/1992	EP0504388A1 Varicella-zoster virus antigen
09/23/1992	EP0504266A1 Nonionic x-ray contrast agents, compositions and methods
09/23/1992	CN1064619A 疾病定位试剂 Positioning disease agents
09/23/1992	CA2063529A1 Booster for therapy of diseases with ultrasound and pharmaceutical liquid composition containing the same
09/22/1992	US5149801 Carboranes, anticarcinogenic agents, boron neutron capture therapy
09/22/1992	US5149708 Photosensitizing Diels-Alder porphyrin derivatives
09/22/1992	US5149543 Ionically cross-linked polymeric microcapsules
09/21/1992	WO1992016498A1 Water soluble, non-ionic x-ray contrasting agents and process for producing the same
09/21/1992	CA2081905A1 Water-soluble, non-ionic x-ray contrast agents and method of preparing them
09/19/1992	WO1992016197A1 Composition and method containing optically pure (s) metoprolol
09/19/1992	CA2106494A1 Composition and method containing optically pure (s) metoprolol
09/16/1992	WO1992016222A1 Methods and compositions for treatment of diabetes mellitus, hypoglycemia, and other conditions
09/16/1992	EP0503505A1 Purified mite allergen
09/16/1992	EP0502897A1 Endothelial-derived il-8
09/16/1992	EP0471792A4 Methods, reagents and test kits for determination of subpopulations of biological entities
09/15/1992	US5147631 Inorganic porous particles entrapping gas or liquid
09/09/1992	EP0502814A2 Compositions for increasing the image contrast in imaging of the digestive tract of patients
09/09/1992	EP0502594A1 Chelates, their metal complexes as well as their use in diagnosis and therapy

1 ... 324 325 326 327 328 329 330 331 332 333 334 335 336 337 338 339 340 341 342 343 344 ... 354